Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation

International Journal of Radiation Biology

Volumn 79, Issue 10, 2003, Pages 817-829

  Mamon, H J ^a,b   Dahlberg, W ^b   Azzam, E I ^b,c   Nagasawa, H ^b   Muto, M G ^a   Little, J B ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; ATAXIA TELANGIECTASIA MUTATED GENE; BREAST CANCER; BREAST CANCER 1 GENE; CELL CYCLE G1 PHASE; CELL LINE; CELL SURVIVAL; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IONIZING RADIATION; MDM2 GENE; MITOSIS INHIBITION; OVARY CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR CELL; WESTERN BLOTTING;

BRCA1 PROTEIN; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; DNA DAMAGE; DNA REPAIR; DNA, NEOPLASM; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, RADIATION; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RADIATION DOSAGE; RECOMBINANT PROTEINS; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0344984281     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/09553000310001610952     Document Type: Article

References (70)

1. ABBOTT, D. W., THOMPSON, M. E., ROBINSON-BENION, C., TOMLINSON, G., JENSEN, R. A. and HOLT, J. T., 1999, BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. Journal of Biological Chemistry, 274, 18808-18812.
2. BAUMANN, P., BENSON, F. E. and WEST, S. C., 1996, Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell, 87, 757-766.
3. BUNDEY, S., 1994, Clinical and genetic features of ataxiatelangiectasia. International Journal of Radiation Biology, 66 (Suppl.), S23-29.
4. CANTOR, S. B., BELL, D. W., GANESAN, S., KASS, E. M., DRAPKIN, R., GROSSMAN, S., WAHRER, D. C., SGROI, D. C., LANE, W. S., HABER, D. A. and LIVINGSTON, D. M., 2001, BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell, 105, 149-160.
5. CHAPMAN, M. S. and VERMA, I. M., 1996, Transcriptional activation by BRCA1 [Letter: Comment]. Nature, 382, 678-679.
6. CHEN, Y., FARMER, A. A., CHEN, C.-F., JONES, D. C., CHEN, P.-L. and LEE, W.-H., 1996, BRCA1 is a 220kDa nuclear phosphoprotein that is expressed and phophorylated in a cell-cycle dependent manner. Cancer Research, 56, 3168-3172.
7. CORTEZ, D., WANG, Y., QIN, J. and ELLEDGE, S. J., 1999, Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks [see comments]. Science, 286, 1162-1166.
8. CUNLIFFE, P. N., MANN, J. R., CAMERON, A. H. and ROBERTS, K. D., 1975, Radiosensitivity in ataxia-telangiectasia. British Journal of Radiology, 48, 374-376.
9. DE TOLEDO, S. M., AZZAM, E. I., DAHLBERG, W. K., GOODING, T. B. and LITTLE, J. B., 2000, ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation. Oncogene, 19, 6185-6193.
10. FALCK, J., MAILAND, N., SYLJUASEN, R. G., BARTEK, J. and LUKAS, J., 2001, The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature, 410, 842-847.
11. FITZGERALD, M. G., BEAN, J. M., HEGDE, S. R., UNSAL, H., MACDONALD, D. J., HARKIN, D. P., FINKELSTEIN, D. M., ISSELBACHER, K. J. and HABER, D. A., 1997, Heterozygous ATM mutations do not contribute to early onset of breast cancer [see comments]. Nature Genetics, 15, 307-310.
12. FORAY, N., MAROT, D., RANDRIANARISON, V., VENEZIA, N. D., PICARD, D., PERRICAUDET, M., FAVAUDON, V. and JEGGO, P., 2002, Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation. Molecular and Cellular Biology, 22, 4020-4032.
13. FORAY, N., RANDRIANARISON, V., MAROT, D., PERRICAUDET, M., LENOIR, G. and FEUNTEUN, J., 1999, Gamma-rays-induced death of human cells earning mutations of BRCA1 or BRCA2. Oncogene, 18, 7334-7342.
14. GARCIA-HIGUERA, I., TANIGUCHI, S., GANESAN, S., MEYN, M. S., TIMMERS, C., HEJNA, J., GROMPE, M. and D'ANDREA, A. M., 2001, Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Molecular Cell, 7, 249-262.
15. GATEI, M., YOUNG, D., CEROSALETTI, K. M., DESAI-MEHTA, A., SPRING, K., KOZLOV, S., LAVIN, M. F., GATTI, R. A., CONCANNON, P. and KHANNA, K., 2000, ATM-dependent phosphorylation of Nibrin in response to radiation exposure. Nature Genetics, 25, 115-119.
16. GEOFFREY-PEREZ, B., JANIN, N., OSSIAN, K., LAUGE, A., STOPPA-LYONNET, D. and ANDRIEU, N., 2002, Variation in breast cancer risk of heterozygotes for ataxia-telangiectasia according to environmental factors. International Journal of Cancer, 99, 619-623.
17. GOWEN, L. C., AVRUTSKAYA, A. V., LATOUR, A. M., KOLLER, B. H. and LEADON, S. A., 1998, BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science, 281, 1009-1012.
18. HAAF, T., GOLUB, E. I., REDDY, G., RADDING, C. M. and WARD, D. C., 1995, Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. Proceedings of the National Academy of Sciences, USA, 92, 2298-2302.
19. HARNDEN, D. G., 1994. The nature of ataxia-telangiectasia: Problems and perspectives. International Journal of Radiation Biology, 66 (Suppl.), S13-19.
20. HAUPT, Y., MAYA, R., KAZAZ, A. and OREN, M., 1997, Mdm2 promotes the rapid degradation of p53. Nature, 387, 296-299.
21. HECHT, F. and HECHT, B. K., 1990, Cancer in ataxia-telangiectasia patients. Cancer Genetics and Cytogenetics, 46, 9-19.
22. HIRAO, A., KONG, Y. Y., MATSUOKA, S., WAKEHAM, A., RULAND, J., YOSHIDA, H., LIU, D., ELLEDGE, S. J. and MAK, T. W., 2000, DNA damage-induced activation of p53 by the checkpoint kinase chk2 [see comments]. Science, 287, 1824-1827.
23. HONDA, R., TANAKA, H. and YASUDA, H., 1997, Oncoprotein Mdm2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Letters, 420, 25-27.
24. KASTAN, M. B., AHAN, Q., EL-DEIRY, W. S., CARRIER, F., JACKS, T., WALSH, W. V., PLUNKETT, B. S., VOGELSTEIN, B. and FORNACE, A. J., 1992, A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587-597.
25. KHOSRAVI, R., MAYA, R., GOTTLIEB, T., OREN, M., SHILOH, Y. and SHKEDY, D., 1999, Rapid ATM-dependent phosphorylation of Mdm2 precedes p53 accumulation in response to DNA damage. Proceedings of the National Academy of Sciences, USA, 96, 14973-14977.
26. KUEBITZ, S. J., PLUNKETT, B. S., WALSH, W. V. and KASTAN, M., 1992, Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proceedings of the National Academy of Sciences, USA, 89, 7491-7495.
27. LARSON, J. S., TONKINSON, J. L. and LAI, M. T., 1997, A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells. Cancer Research, 57, 3351-3355.
28. LAVIN, M. F., CONCANNON, P. and GATTI, R. A., 1999, Eighth international workshop on ataxia-telangiectasia (ATW8). Cancer Research, 59, 3845-3849.
29. LEE, J. S., COLLINS, K. M., BROWN, A. L., LEE, C. H. and CHUNG, J. H., 2000, Hcds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature, 404, 201-204.
30. 1 arrest in established human tumor cell lines. Oncogene, 11, 1885-1892.
31. LI, S., TING, N. S., ZHENG, L., CHEN, P. L., ZIV, Y., SHILO, Y., LEE, E. Y. and LEE, W.-H., 2000, Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature, 406, 210-215.
32. LIM, D. S., KIM, S. T., XU, B., MASER, R. S., LIN, J., PETRINI, J. H. and KASTAN, M. B., 2000, ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature, 404, 613-617.
33. LITTLE, J. B., 1969, Repair of sub-lethal and potentially lethal radiation damage in plateau phase cultures of human cells. Nature, 224, 804-806.
34. LITTLE, J. B. and NAGASAWA, H., 1985. Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia-telangiectasia fibroblasts. Radiation Research, 101, 81-93.
35. MEYN, M. S., 1993, High spontaneous intrachromosomal recombination rates in ataxia-telangiectasia. Science, 260, 1327-1330.
36. MOMAND, J., ZAMBETTI, G. P., OLSON, D. C., GEORGE, D. and LEVINE, A. J., 1992, The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245.
37. MOYNAHAN, M. E., CHIU, J. W., KOLLER, B. H. and JASIN, M., 1999, BRCA1 controls homology-directed DNA repair. Molecular Cell, 4, 511-518.
38. NAGASAWA, H., LATT, S. A., LALANDE, M. E. and LITTLE, J. B., 1985, Effects of x-irradiation on cell-cycle progression, induction of chromosomal aberrations and cell killing in ataxia telangiectasia (AT) fibroblasts. Mutation Research, 148, 71-82.
39. NAGASAWA, H. and LITTLE, J. B., 1981, Induction of chromosome aberrations and sister chromatid exchanges by x rays in density-inhibited cultures of mouse 10T1/2 cells. Radiation Research, 87, 538-551.
40. NAGASAWA, H. and LITTLE, J. B., 1983, Comparison of kinetics of x-ray-induced cell killing in normal, ataxia telangiectasia and hereditary retinoblastoma fibroblasts. Mutation Research, 109, 297-308.
41. NICHOLS, K. E., LEVITZ, S., SHANNON, K. E., WAHRER, D. C., BELL, D. W., CHANG, G., HEDGE, S., NEUBERG, D., SHAFMAN, T., TARBELL, N. J., MAUCH, P., ISHIOKA, C., HABER, D. A. and DILLER, L., 1999. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease. Journal of Clinical Oncology, 17, 1259-1266.
42. OUCHI, T., MONTEIRO, A. N., AUGUST, A., AARONSON, S. A. and HANAFUSA, H., 1998, BRCA1 regulates p53-dependent gene expression. Proceedings of the National Academy of Sciences, USA, 95, 2302-2306.
43. PAINTER, R. B. and YOUNG, B. R., 1980. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proceedings of the National Academy of Sciences, USA, 77, 7315-7317.
44. PICKSLEY, S. M., VOJTESEK, B., SPARKS, A. and LANE, D. P., 1994, Immunochemical analysis of the interaction of p53 with MDM2-fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene, 9, 2523-2529.
45. PIPPARD, E. C., HALL, A. J., BARKER, D. J. and BRIDGES, B. A., 1988, Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Research, 48, 2929-2932.
46. PRITCHARD, J., SANDLAND, M. R., BREATNACH, F. B., PINCOTT, J. R., COX, R. and HUSBAND, P., 1982. The effects of radiation therapy for Hodgkin's disease in a child with ataxia telangiectasia: A clinical, biological and pathologic study. Cancer, 50, 877-886.
47. SAVITSKY, K., BAR-SHIRA, A., GILAD, S., ROTMAN, G., ZIV, Y., ZIV, VANAGAITE, L., TAGLE, D. A., SMITH, S., UZIEL, T. and SFEZ, S., et al. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science, 268, 1749-1753.
48. SCOTT, S. P., BENDIX, R., CHEN, P., CLARK, R., DORK, T. and LAVIN, M. F., 2002. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer. Proceedings of the National Academy of Sciences, USA, 99, 925-930.
49. SCULLY, R., GANESAN, S., VLASAKOVA, K., CHEN, J., SOCOLOVSKY, M. and LIVINGSTON, D. M., 1999, Genetic analysis of BRCA1 function in a defined tumor cell line. Molecular Cell, 4, 1093-1099.
50. SCULLY, R., ANDERSON, S. F., CHAO, D. M., WEI, W., YE, L., YOUNG, R. A., LIVINGSTON, D. M. and PARVIN, J. D., 1997a, BRCA1 is a component of the RNA polymerase II holoenzyme. Proceedings of the National Academy of Sciences, USA, 94, 5605-5610.
51. SCULLY, R., CHEN, J., OCHS, R. L., KEEGAN, K., HOEKSTRA, M., FEUNTEUN, J. and LIVINGSTON, D. M., 1997b, Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell, 90, 425-435.
52. SCULLY, R., CHEN, J., PLUG, A., XIAO, Y., WEAVER, D., FEUNTEUN, J., ASHLEY, T. and LIVINGSTON, D. M., 1997c, Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell, 88, 265-275.
53. SHAFMAN, T. D., LEVITZ, S., NIXON, A. J., GIBANS, L. A., NICHOLS, K. E., BELL, D. W., ISHIOKA, C., ISSELBACHER, K. J., GELMAN, R., GARBER, J., HARRIS, J. R. and HABER, D. A., 2000, Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor. Genes Chromosomes and Cancer, 27, 124-129.
54. SHEN, S.-X., WEAVER, Z., XU, X., LI, C., WEINSTEIN, M., CHEN, L., GUAN, X.-Y., RIED, T. and DENG, C.-X., 1998, A targeted disruption of the murine Brca1 gene causes γ-irradiation hypersensitivity and genetic instability. Oncogene, 17, 3115-3124.
55. SOMASUNDARAM, K., ZHANG, H., ZENG, Y. X., HOUVRAS, Y., PENG, Y., WU, G. S., LICHT, J. D., WEBER, B. L. and EL-DEIRY, W. S., 1997, Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/Cip1. Nature, 389, 187-190.
56. SOMMER, S. S., BUZIN, C. H., JUNG, M., ZHENG, J., LIU, Q., JEONG, S. J., MOULDS, J., NGUYEN, V. Q., FENG, J., BENNETT, W. P. and DRITSCHILO, A., 2002, Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controls. Cancer Genetics and Cytogenetics, 134, 25-32.
57. SWIFT, M., 2001, Public health burden of cancer in ataxia-telangiectasia heterozygotes. Journal of the National Cancer Institute, 93, 84-85.
58. TAYLOR, A. M., HARNDEN, D. G., ARLETT, C. F., HARCOURT, S. A., LEHMANN, A. R., STEVENS, S. and BRIDGES, B. A., 1975, Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature, 258, 427-429.
59. TERAOKA, S. N., MALONE, K. E., DOODY, D. R., SUTER, N. M., OSTRANDER, E. A., DALING, J. R. and CONCANNON, P., 2001, Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer, 92, 479-487.
60. THACKER, J., 1994, Cellular radiosensitivity in ataxia-telangiectasia. International Journal of Radiation Biology, 66, S87-S96.
61. TOMLINSON, G. E., CHEN, T. T., STASTNY, V. A., VIRMANI, A. K., SPILLMAN, M. A., TONK, V., BLUM, J. L., SCHNEIDER, N. R., WISTUBA II, SHAY, J. W., MINNA, J. D. and GAZDAR, A. F., 1998, Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Research, 58, 3237-3242.
62. VAUGHN, J. P., DAVIS, P. L., JARBOE, M. D., HUPER, G., EVANS, A. C., WISEMAN, R. W., BERCHUCK, A., IGLEHART, J. D., FUTREAL, P. A. and MARKS, J. R., 1996, BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth and Differentiation, 7, 711-715.
63. WANG, Y., CORTEZ, D., YAZDI, P., NEFF, N., ELLEDGE, S. J. and QIN, J., 2000, BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes and Development, 14, 927-939.
64. WEICHSELBAUM, R. R., NOVE, J. and LITTLE, J. B., 1978, Deficient recovery from potentially lethal radiation damage in ataxia telangiectasia and xeroderma pigmentosum. Nature, 271, 261-262.
65. WU, X., RANGANATHAN, V., WEISMAN, D. S., HEINE, W. F., CICCONE, D. N., O'NEILL, T. B., CRICK, K. E., PIERCE. K. A., LANE, W. S., RATHBUN, G., LIVINGSTON, D. M. and WEAVER, D. T., 2000, ATM phosphorylation of Nijmegen Breakage Syndrome protein is required in a DNA damage response [see comments]. Nature, 405, 477-482.
66. 2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Molecular Cell, 3, 389-395.
67. ZHANG, H., SONASUNDARAM, K., PENG, Y., TIAN, H., BI, D., WEBER, B. L. and EL-DEIRY, W. S., 1998, BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene, 16, 1713-1721.
68. ZHAO, S., WENG, Y. C., YUAN, S. S., LIN, Y. T., HSU, H. C., LIN, S. C., GERBINO, E., SONG, M. H., ZDZIENICKA, M. Z., GATTI, R. A., SHAY, J. W., ZIV, Y., SHILOH, Y. and LEE, E. Y., 2000, Functional link between ataxia-telangiectasia and Nijmegen Breakage Syndrome gene products [see comments]. Nature. 405, 473-477.
69. ZHONG, Q., CHEN, C.-F., CHEN, P.-L. and LEE, W.-H., 2002, BRCA1 facilitates microhomology-mediated end joining of DNA double strand breaks. Journal of Biological Chemistry, 277, 28641-28647.
70. ZHOU, B. B. and ELLEDGE, S. J., 2000, The DNA damage response: putting checkpoints in perspective. Nature, 408, 433-439.